With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Understanding and Preventing Healthy Tissue Damage in Pediatric Cancer Patients||Dana-Farber Cancer Institute / Kristopher Sarosiek, PhD||Young Investigator Grants||2014||Massachusetts|
|Understanding factors contributing to retention in care among children with cancer in sub-Saharan Africa||Baylor College of Medicine / Mark Zobeck, MD, PhD||Psychosocial Launch Grant||2019||Texas|
|Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML||Boston Children's Hospital / Anne Robertson, PhD||Young Investigator Grants||2017||Massachusetts|
|Understanding the Role of a Novel Hereditary Cancer Gene||University of Texas Health Science Center at San Antonio / Patricia Dahia||Innovation Grants||2010||Texas|
|Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma||University of California San Francisco / Ozlem Aksoy, PhD||Young Investigator Grants||2015||California|
|Untangling the Matrix in Medulloblastoma||St. Christopher's Hospital for Children / Duncan Stearns, MD||Young Investigator Grants||2008||Ohio|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|
|Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy||Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD||Innovation Grants||2019||Ohio|
|Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia||Dana-Farber Cancer Institute / Evisa Gjini||Young Investigator Grants||2011||Massachusetts|
|V alpha-invariant NKT cells as a novel platform for cancer immunotherapy||Baylor College of Medicine / Leonid Metelitsa, MD, PhD||Innovation Grants||2012||Texas|